This stack has gained significant attention in research communities because it addresses a frustrating reality: standard weight loss often reduces subcutaneous fat (the pinchable fat under your skin) while leaving visceral fat largely intact
Each compound clears a different bottleneck at the same dermal target: Collagen quality and firmness GHK-Cu activates collagen-gene transcription and supplies the copper cofactor for cross-linking Microvascular delivery BPC-157 builds the capillary network that feeds active tissue Organized tissue, scar remodeling full-length TB-4 mobilizes repair cells with anti-scarring bias General timeline of benefits: hydration and texture by 24 weeks, fine lines softening by 48, firmer structure and scar remodeling by 812
Schiff RD, Mertelsmann R, Andreeff M , Gee TS, Kempin SJ, Koziner BL, Lee BJ, Clarkson BD
10.2147/JMDH.S419245 16
TB-500 in G-actin sequestration, endothelial and keratinocyte migration, and cardiac and corneal repair models, with randomised placebo-controlled human data existing only for thymosin beta 4 as a topical ophthalmic formulation
1 Because levothyroxine is a daily tablet and Wegovy is a weekly injection, their timing is independent, so the two dont need to align